Tango Therapeutics, Inc. (TNGX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TNGX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 237 institutions reported holding TNGX, with 213.7 million shares worth $6.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Rtw Investments | 13,900,620 | $435M | INCREASED |
| BlackRock | 12,438,444 | $389M | INCREASED |
| FMR | 12,333,339 | $386M | INCREASED |
| Farallon Capital Management | 12,277,000 | $384M | INCREASED |
| Boxer Capital Management | 10,876,219 | $340M | UNCHANGED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jessica Newcomb (Principal Accounting Officer) | SELL | 1,460 | $34K | 2026-11-02 |
| Jessica Newcomb (Principal Accounting Officer) | SELL | 5,571 | $124K | 2026-11-02 |
| Adam Crystal (President, R&D) | EXERCISE | 5,000 | $15K | 2026-11-02 |
| Adam Crystal (President, R&D) | SELL | 1,100 | $25K | 2026-11-02 |
| Adam Crystal (President, R&D) | SELL | 3,900 | $87K | 2026-11-02 |
Full institutional holdings, insider history, and congressional trades for Tango Therapeutics, Inc. on SentiSense.